IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)
暂无分享，去创建一个
E. Hoster | W. Hiddemann | K. Rufibach | M. Herold | M. Trněný | G. Fingerle-Rowson | A. Rosta | H. McCarthy | C. Pocock | A. Burciu | P. Schmidt | H. Zeuner | R. Marcus | A. Tedeschi | A. Janssens | K. Rufibach | A. Rosta